Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma
This 2 arm randomized clinical trial will assess the impact of Dienogest and N-Acetyl Cysteine on volume reduction of uterine leiomyoma
Uterine Leiomyoma
DRUG: Dienogest 2 MG|DRUG: N-acetyl cysteine
leiomyoma size reduction, vertical x horizontal diameter in mm by transvaginal U/S, 3 months
Dysmenorrhea, according to the visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. The scale is composed of 0 (no pain at all) to 10 (worst imaginable pain), 3 Monthes|heavy menstrual bleeding, assess by PBAC score, 3 months|blood loss, by hemoglobin level, 3 months
Group A women will receive Dienogest orally 2mg pills daily for 3 months .20 cases Group B women will receive NAC orally at a dose of 600 mg/day for 3 months ,20 cases